Treatment of amiodarone iodine-induced thyrotoxicosis is often unsuccessful. Nevertheless, severe forms require a rapidly efficient therapy. Twelve patients with severe amiodarone iodine-induced thyrotoxicosis, as demonstrated on clinical and biological findings, were studied. After amiodarone withdrawal, 6 patients (group A) were treated with thionamides alone (carbimazole 60 mg daily and benzylthiouracile 1.5 g daily), and 6 patients (group B) received in addition to the same antithyroid drugs prednisone, 0.50 to 1.25 mg/kg/day for 40 days; in group A, T4 levels did not change over the study period of 40 days; T3 levels decreased only after 30 days; clinical status did not improve. In group B: T3 and T4 levels decreased dramatically at 10 days of treatment, to values significantly lower than in group A; clinical improvement occurred mainly in patients treated with high doses of prednisone; elevated thyroglobulin levels diminished rapidly. Improvement was maintained after cessation of prednisone. The rapid effect of prednisone suggests an impairement of proteolysis of thyroglobulin possibly due to a lysosomal action.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF03349916DOI Listing

Publication Analysis

Top Keywords

amiodarone iodine-induced
12
iodine-induced thyrotoxicosis
12
severe amiodarone
8
patients group
8
group levels
8
levels decreased
8
prednisone
5
patients
5
group
5
rapid effectiveness
4

Similar Publications

Iodine and Hyperthyroidism: A Double-Edged Sword.

Endocr Pract

November 2024

Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts. Electronic address:

Objective: This article serves as an update to a 1995 review by Braverman and Roti that was publishsed in the inaugural issue of Endocrine Practice.

Methods: We searched PubMed for relevant English-language literature and identified additional papers cited in recent reviews.

Results: Iodine is a trace element found in the Earth's crust that is necessary for the biosynthesis of thyroid hormones.

View Article and Find Full Text PDF

Utility of ultra-portable ultrasound devices for the risk-stratification of thyroid dysfunctions in an emergency setting.

J Endocrinol Invest

October 2024

Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy.

Article Synopsis
  • The study examines the effectiveness of rapid TSH screening in detecting thyroid diseases in patients in the Emergency Department (ED), noting a 7% prevalence of previously undiagnosed thyroid dysfunctions.
  • The diagnostic process was enhanced by using a mobile ultrasound device, rPOCUS, to evaluate patients with suppressed rTSH in urgent care situations requiring iodinated contrast.
  • Results indicate that rPOCUS is both cost- and time-effective, aiding in the management of hyperthyroidism, reducing unnecessary rTSH tests, and identifying incidental findings that necessitate further evaluation.
View Article and Find Full Text PDF
Article Synopsis
  • * A systematic review was conducted to assess current guidelines and clinical trials related to the effectiveness and safety of perchlorates in various forms of hyperthyroidism, including Graves' disease and pregnancy-related issues.
  • * Despite limitations in existing studies, perchlorates could be regarded as a second-line treatment option for iodine-related hyperthyroidism and thyroid storm, especially when other treatments are not viable.
View Article and Find Full Text PDF

The Jod-Basedow phenomenon (JB phenomenon), also referred to as "iodine-induced hyperthyroidism," rarely occurs. Radiological imaging using iodinated contrast contains a dose of 300 to 1221 mg of iodine per kilogram, which can transiently induce clinically significant hyperthyroidism (referred to as Jod-Basedow Syndrome) in euthyroid patients. Hence, the reporting of such events is important for clinicians to be aware of, to prevent unnecessary iodine-based imaging.

View Article and Find Full Text PDF

Severe thyrotoxicosis is an acute and life-threatening state of hyperthyroidism. While it is a rare presentation of hyperthyroidism, it is clinically significant because of its high mortality and necessitates early identification and treatment to reduce the incidence of poor outcomes. The most common causes of this hypermetabolic state are Graves' disease, toxic thyroid adenoma or multinodular goiter, thyroiditis, iodine-induced hyperthyroidism, and excessive intake of levothyroxine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!